Michael Russell, PhD, an emeritus professor of microbiology and immunology at the University at Buffalo in New York believes that nasal vaccines are of a better advantage as the look for products that will be easier to store, transport, and administer in the global crisis. While more data has suggested the vaccines authorized in the U.S. cut transmission, some experts have argued that intranasal vaccines may do an even better job.